---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-242652"
form_type: "8-K"
ticker: "LXEO"
cik: "0001907108"
company_name: "Lexeo Therapeutics, Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:26:28.050261+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lexeo prices $135M offering; FDA open to faster LX2006 approval path

## Summary
- Priced public offering of 15.625M shares at $8.00 and $10M private placement (pre-funded warrants) to Balyasny; gross proceeds ~$135M.
- Preliminary cash, cash equivalents and investments of $122.8M as of Sept 30, 2025.
- FDA indicated openness to accelerated BLA for LX2006 using pooled Phase I/II and pivotal study data; enhanced manufacturing comparability required.
- LX2006 interim data: sustained or deepening improvements in LVMI and frataxin in majority of 16 participants at >=6 months follow-up.
- LX2020: 9 participants dosed; one Grade 3 SVT resolved; low-dose cohort shows stable cardiac parameters; more data expected Jan 2026.

## SEC filing metadata
- accession: 0001193125-25-242652
- form_type: 8-K
- ticker: LXEO
- cik: 0001907108
- company_name: Lexeo Therapeutics, Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907108/000119312525242652/0001193125-25-242652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907108/000119312525242652/d52644d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-242652
- JSON: https://secwatch.observer/filing/0001193125-25-242652.json
- Plain text: https://secwatch.observer/filing/0001193125-25-242652.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.